Second primary malignancies of cancer patients: treatment-related carcinogenesis
Cytostatic drugs used in chemotherapy cause secondary tumors in some patients cured of the antecedent neoplasm. Thus the incidence of second neoplasia for cancer survivors compared with the general population represents a 4-fold to 6-fold increased risk.The review presents recent data on the mechani...
Saved in:
| Main Authors: | G. A. Belitskiy, E. A. Lesovaya, K. I. Kirsanov, M. G. Yakubovskaya |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2016-09-01
|
| Series: | Успехи молекулярной онкологии |
| Subjects: | |
| Online Access: | https://umo.abvpress.ru/jour/article/view/69 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predictors of Multiple Primary Malignancies: Literature Review
by: A. V. Sultanbaev, et al.
Published: (2023-10-01) -
Mechanisms of carcinogenesis prevention by flavonoids
by: G. A. Belitsky, et al.
Published: (2015-06-01) -
Second primary malignancies in cancer survivors: epidemiology, role of anticancer therapy
by: L. G. Solenova
Published: (2016-09-01) -
The role of methionine cycle disruption in the initiation and progression of malignant tumors
by: T. G. Ruksha, et al.
Published: (2024-12-01) -
WHO HAS THERAPY-RELATED AML?
by: Robert Gale, et al.
Published: (2017-03-01)